Literature DB >> 17440602

Abnormal Beckmann fragmentation/ring closing metathesis route for preparation of 18-nor-Delta-androgens and their 18-nor-13,17-epoxide derivatives.

Cunde Wang1, Nigam P Rath, Douglas F Covey.   

Abstract

The synthesis of Delta(13,(17))-androgens and the structurally related 13,17-epoxides is described. The synthetic route involves cleavage of 17-ketosteroids by an abnormal Beckmann rearrangement, modification of the D-ring cleavage product to obtained an intermediate tricyclic diene and ring closing metathesis of the diene to the Delta(13,(17))-androgen. (3alpha,5alpha)-Androst-13(17)-en-3-ol and the derivative 13alpha,17alpha- and 13beta,17beta- epoxides were prepared by this route.

Entities:  

Year:  2006        PMID: 17440602      PMCID: PMC1852443          DOI: 10.1016/j.tetlet.2006.09.027

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN: 0040-4039            Impact factor:   2.415


  5 in total

1.  Synthesis of trisubstituted alkenes via olefin cross-metathesis.

Authors:  A K Chatterjee; R H Grubbs
Journal:  Org Lett       Date:  1999-12-02       Impact factor: 6.005

2.  Structure-activity relationships in steroidal anaesthetics.

Authors:  G H Phillipps
Journal:  J Steroid Biochem       Date:  1975-05       Impact factor: 4.292

Review 3.  Neurosteroids: endogenous regulators of the GABA(A) receptor.

Authors:  Delia Belelli; Jeremy J Lambert
Journal:  Nat Rev Neurosci       Date:  2005-07       Impact factor: 34.870

4.  Synthesis and activity of a new generation of ruthenium-based olefin metathesis catalysts coordinated with 1,3-dimesityl-4,5-dihydroimidazol-2-ylidene ligands.

Authors:  M Scholl; S Ding; C W Lee; R H Grubbs
Journal:  Org Lett       Date:  1999-09-23       Impact factor: 6.005

5.  Conformationally constrained anesthetic steroids that modulate GABA(A) receptors.

Authors:  A Anderson; A C Boyd; J K Clark; L Fielding; D K Gemmell; N M Hamilton; M S Maidment; V May; R McGuire; P McPhail; F H Sansbury; H Sundaram; R Taylor
Journal:  J Med Chem       Date:  2000-11-02       Impact factor: 7.446

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.